Pierre Fabre Medicament Polska .sp. z o.o.

Wholesale trade, except of motor vehicles

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-05-09
Share capital
1,200,000.00 PLN
Registered address
Belwederska 20/22, 00-762 Warszawa, Poland
Website
pierre-fabre.com
Email
Social media
Electronic delivery address
AE:PL-46512-20993-IRCBS-21

Financials

Total Operating Costs
83.58m
+7.5% vs 2024

Revenue history (in m)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 13 days late). All were audited by a statutory auditor.

  • 202507/07/2026
  • 202404/06/2025
  • 202305/06/2024
  • 202204/07/2023
  • 202128/07/2022
  • 202015/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

City · Warszawa714 / 56,958
Top 1.3%
Voivodeship · Mazowieckie923 / 77,118
Top 1.2%
Country · Poland2,597 / 297,873
Top <1%

Results vs city

Revenue
This companyUSD 87.31mMedianUSD 139.39kAverageUSD 5.47m
Net profit
This companyUSD 1.91mMedianUSD 1.45kAverageUSD 303.08k
Operating costs
This companyUSD 83.58mMedianUSD 115.96kAverageUSD 4.61m
Assets
This companyUSD 33.29mMedianUSD 156.10kAverageUSD 12.09m

News

Laboratoires Pierre Fabre Launches New Employer Brand "We Care Movement"

Laboratoires Pierre Fabre Launches New Employer Brand "We Care Movement"

Marie-Andrée Gamache Appointed CEO of Medical Care at Pierre Fabre

Marie-Andrée Gamache Appointed CEO of Medical Care at Pierre Fabre

Breast Cancer Awareness Month – Pierre Fabre Campaign

Pierre Fabre 2025 Annual Report Under the Theme of New Energy

Industry

Offer

  • Prescription medicines
  • Oncology medicines
  • Medicines for chronic diseases
  • Dermocosmetics
  • Skin care
  • Hair care

Website technology

Analytics and marketing
  • Google Tag Manager

Trademarks

Pierre Fabre Medicament Polska . currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2004.

MarkNumberClassesStatusProtected until
DBAJ O ZĘBY PROBLEMY STOMATOLOGICZNE HIGIENA JAMY USTNEJ TU UZYSKASZ PORADĘZ.2827243Proceedings discontinued –
MarkProtected until
DBAJ O ZĘBY PROBLEMY STOMATOLOGICZNE HIGIENA JAMY USTNEJ TU UZYSKASZ PORADĘ–

Authorized Representatives

Beata Dobicka Miś – Management Board Member
Sylvie Marina Gil – President of the Management Board

Manner of representation

In the case of a one-person management board, the President of the Management Board independently; if the management board consists of more than one person, the President of the Management Board independently, two members of the management board acting jointly, or a member of the management board jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Pierre Fabre Medicament Sas
1,200$324,149.11100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2000-08-28.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Gilead Sciences Polandsp. z o.o.
Abbott Medicalsp. z o.o.
Amgensp. z o.o.
Zentiva Polskasp. z o.o.
Angelini Pharma Polskasp. z o.o.
Stada Pharmsp. z o.o.
Olympus Polskasp. z o.o.
Magnapharm Polandsp. z o.o.
Kol-Dentalsp. z o.o. + limited partnership
ITPS.A.

Change history

DateEvent
2004-01-26Share capital increase
2001-05-09Entered in the register

FAQ

Last updated: 2026-10-07